SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011074
Filing Date
2021-08-10
Accepted
2021-08-10 09:11:42
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q btai-20210630x10q.htm   iXBRL 10-Q 1575015
2 EX-3.1 btai-20210630xex3d1.htm EX-3.1 62789
3 EX-10.1 btai-20210630xex10d1.htm EX-10.1 53729
4 EX-31.1 btai-20210630xex31d1.htm EX-31.1 17703
5 EX-31.2 btai-20210630xex31d2.htm EX-31.2 16859
6 EX-32.1 btai-20210630xex32d1.htm EX-32.1 10351
7 EX-32.2 btai-20210630xex32d2.htm EX-32.2 8719
8 GRAPHIC btai-20210630x10q006.jpg GRAPHIC 209082
  Complete submission text file 0001558370-21-011074.txt   5328679

Data Files

Seq Description Document Type Size
9 EX-101.SCH btai-20210630.xsd EX-101.SCH 26204
10 EX-101.CAL btai-20210630_cal.xml EX-101.CAL 32496
11 EX-101.DEF btai-20210630_def.xml EX-101.DEF 82186
12 EX-101.LAB btai-20210630_lab.xml EX-101.LAB 280831
13 EX-101.PRE btai-20210630_pre.xml EX-101.PRE 207482
14 EXTRACTED XBRL INSTANCE DOCUMENT btai-20210630x10q_htm.xml XML 626740
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 211158633
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences